Soldier Health. World Health.
The US Military’s HIV Research Program (MHRP) is at the forefront of the battle against HIV to protect
US troops and reduce the global impact of the disease.
A new large-scale HIV vaccine study will launch based on the landmark Army-led RV144 “Thai study,” the first vaccine trial to show efficacy.
Learn MoreOur novel acute cohorts provide insights into critical moments of HIV infection in the hopes of finding a possible cure for HIV.
Learn MoreWith MHRP support, Army scientists at are moving quickly to test a ZPIV vaccine candidate.
Read MoreThe Joint West Africa Research Group is leveraging existing platforms and relationships to counter emerging infections in the region.
Read MoreThe US Military’s HIV Research Program (MHRP) is at the forefront of the battle against HIV to protect
US troops and reduce the global impact of the disease.
MHRP researchers and Thai collaborators are leading the way in acute infection studies. One study, called RV254/SEARCH 010 is providing knowledge about the earliest HIV events that may provide clues to developing an effective HIV vaccine or even help identify ways to achieve a functional cure. MHRP spoke with people living with HIV in Thailand about the impact a potential cure would have on their lives.
© 2016 U.S. Military HIV Research Program, Terms of Use & Disclaimer